DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Toloxatone

Toloxatone

  • Summary of Product Characteristics

    Summary of Product Characteristics

  • Official Protocol Title: NCT Number: NCT02750761

    Official Protocol Title: NCT Number: NCT02750761

  • Differential Inhibition of Neuronal and Extraneuronal Monoamine Oxidase Graeme Eisenhofer, Ph.D., Jacques W

    Differential Inhibition of Neuronal and Extraneuronal Monoamine Oxidase Graeme Eisenhofer, Ph.D., Jacques W

  • 1 Supplemental Figure 1: Illustration of Time-Varying

    1 Supplemental Figure 1: Illustration of Time-Varying

  • In Utero Exposure to Antidepressant Drugs and Risk of Attention Deficit Hyperactivity Disorder (ADHD)

    In Utero Exposure to Antidepressant Drugs and Risk of Attention Deficit Hyperactivity Disorder (ADHD)

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period

    Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period

  • 395 B 536 Winstal. O. Saito EEEEEE

    395 B 536 Winstal. O. Saito EEEEEE

  • Special Article: One Resident's Perspective on a Different Style of Psychopharmacological Practice

    Special Article: One Resident's Perspective on a Different Style of Psychopharmacological Practice

  • Focus on Moclobemide

    Focus on Moclobemide

  • Antidepressant Treatment for Postnatal Depression

    Antidepressant Treatment for Postnatal Depression

  • Patil AJ and Suryawanshi MR. Review on Novel Monoamine Oxidase Inhibitors: a Clinician’S Guide

    Patil AJ and Suryawanshi MR. Review on Novel Monoamine Oxidase Inhibitors: a Clinician’S Guide

  • Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum)

    Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum)

  • Antidepressant Drugs-1

    Antidepressant Drugs-1

  • On the Clinical Pharmacology of Reactive Oxygen Species

    On the Clinical Pharmacology of Reactive Oxygen Species

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • Meta-Analysis of the Reversible Inhibitors of Monoamine Oxidase

    Meta-Analysis of the Reversible Inhibitors of Monoamine Oxidase

  • Package Leaflet: Information for the User

    Package Leaflet: Information for the User

Top View
  • Potent Selective Inhibition of Monoamine Oxidase a By
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • The Antidepressant Properties of Selected Methylene Blue Analogues ~
  • CCDAN Search Strategies (All Antidepressants)
  • (ATC) Classification Codes for Antidepressants
  • Pharmaabkommen A1 E
  • Reversible Inhibitors of Monoamine Oxidase-A (Rimas): Robust, Reversible Inhibition of Human Brain MAO-A by CX157
  • Neuronal and Immunological Basis of Action of Antidepressants in Chronic
  • Customs Tariff - Schedule Xxi - 1
  • Monoamine Oxidase MAO
  • (12) Patent Application Publication (10) Pub. No.: US 2005/0002865 A1 Klaveness Et Al
  • Package Leaflet: Information for the User
  • Harmine and Piperlongumine Revert TRIB2-Mediated Drug Resistance
  • Study Protocol
  • Study Protocol
  • Antidepressants and Movement Disorders
  • Effect of Serotonin Modulation on Dystrophin-Deficient Zebrafish Janelle M
  • Appendix & Tables


© 2024 Docslib.org    Feedback